Skip to main content


Call for Abstract Submissions is
Now Open!


Put a Spotlight on Your Innovative Research

The CRS 2023 Annual Meeting & Expo offers an exceptional opportunity to share your research with an international audience of experts in the design, development, and implementation of novel delivery technologies.


Review Procedure

All abstracts submitted to the CRS 2023 Annual Meeting & Expo will go through a rigorous review process to maintain the highest scientific quality of the meeting. The abstract will be evaluated by the CRS Annual Meeting Program Committee and will be assigned a rank order based on its scientific content.  Some abstracts will be selected for oral presentations during regular scientific sessions.  Abstracts will be rejected if they do not comply with minimum submission instructions, do not follow the proper format, and/or do not include all required fields.

Submitted Abstracts Must Meet the Following Minimum Requirements:

  • Significant and original contribution within the scope of the Controlled Release Society.
  • Abstract submitted by the deadline.
  • Written in clear English with minimum syntax/spelling errors.
  • Minimum syntax/spelling mistakes.
  • Sufficient data presented, adequately analyzed, and discussed with appropriate conclusions supported by the data.
  • Meets format guidelines.

Process for Abstract Selection

  • All abstracts must not have been previously submitted for consideration at another meeting.
  • The criterion for acceptance of presentation at the CRS Annual Meeting & Expo is based on a peer-review process.
  • The authors must obtain any necessary permissions prior to submission of the abstract.
  • The CRS Annual Meeting Program Committee reserves the right to evaluate, accept, or reject any submitted abstract. The committee will determine the status (accept or reject) of all submitted abstracts and the placement (oral or poster presentation) of all accepted abstracts. The committee may also switch abstracts to any topic category based on their evaluation and organization requirements.


Session Topics and Descriptions for Abstracts


  • Bioengineering: Topics include bioinspired and biomimetic strategies (e.g. Mimicking the physicochemical and physiological properties of natural particulates, ranging from pathogens to mammalian cells) for the design of advanced drug delivery systems.
  • Nervous system delivery: Topics related to barriers and approaches for delivery to the central nervous system.
    Nanomedicine and nanoscale delivery: Topics include nanomedicine and biomedical nanotechnology for the design of advanced drug delivery systems.
  • Nanomedicine and nanoscale delivery: Topics include nanomedicine and biomedical nanotechnology for the design of advanced drug delivery systems.
  • Ocular delivery: Topics include challenges and opportunities unique to the treatment of vision-threatening diseases.
  • New and emerging technologies for drug delivery: Topics include the application and convergence of new technologies in drug delivery technologies, including the use of artificial intelligence, big data, and precision medicine.
  • Immunodelivery: Topics related to new approaches in drug delivery to selectively target immune cells in peripheral tissues, diseased tissues, and at the primary sites of immunological reactions.
  • Transdermal and mucosal delivery: Topics related to challenges/barriers encountered, and novel strategies to overcome transdermal and mucosal barriers to formulation development.
  • Delivery technologies in cosmetic and consumer products: Topics related to recent developments in design and manufacturing of controlled release solutions in personal and home care areas, such as cosmetics, cosmeceuticals, skin care, deodorants, antiperspirants, hair care, mouth care, air fresheners, and cleaning and sanitizing agents.
  • Sustainability and veterinary health: Topics related to agriculture, aquaculture, pesticides, and other efforts toward sustainability. Includes all topics related to veterinary healthcare.
  • Gene delivery and gene editing: Topics include nucleic acid-based approaches for generating therapeutic proteins, eliminating disease-causing proteins, and precisely editing the genome.
  • Oral delivery: Topics related to formulation and manufacturing of small molecule and biologic drugs to maximize their oral bioavailability. Includes nutraceuticals and food and beverages as delivery vehicles.
  • New developments in characterization and process scale up: Topics related evaluation and characterization of delivery products, as well as their preparation and process scale up, including Quality-by-design (QbD) concepts and process analytical technologies. Further included topics are additive manufacturing and innovative green technologies (e.g. use of natural, non-modified, renewable materials).
  • Global health and special populations: Topics related to global diseases and diseases affecting developing countries. Includes topics with application in special populations (women, children, the elderly), and research with a focus on equality, diversity, and inclusion (ED&I).

Abstract Submissions Deadline: February 28, 2023


Submit Abstracts Here            Abstracts Guidelines


Countdown to Las Vegas!

mailtimers.com